AI
TLSA icon

Atria Investments’s Tiziana Life Sciences TLSA Stock Holding History

Atria Investments’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,718
Closed -$8.85K – 1997
2024
Q4 		$8.85K Buy
+12,718
New +$11.8K ﹤0.01% 1846

Other funds holding TLSA

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Atria Investments's TLSA Position: Q1 2025 in Review

Atria Investments sold out of Tiziana Life Sciences (TLSA) in Q1 2025, closing a stake of 12,718 shares — an estimated $8.85K sold.

Atria Investments first reported a position in TLSA in Q4 2024 and held it in 1 quarter. The position peaked at $8.85K in Q4 2024. 32 funds tracked by Wall St. Rank hold TLSA as of Q1 2025.

  • Atria Investments reported no remaining Tiziana Life Sciences position as of Q1 2025 after selling out during the quarter.
  • Atria Investments sold 12,718 Tiziana Life Sciences shares in Q1 2025, an estimated $8.85K.
  • Atria Investments first reported a position in Tiziana Life Sciences in Q4 2024 and held it in 1 quarter.
  • Atria Investments's Tiziana Life Sciences position peaked at $8.85K in Q4 2024.
  • 32 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2025.

Based on Atria Investments's 13F filing for Q1 2025, filed 6 May 2025.